Variation and molecular evolution of HmbR, the Neisseria meningitidis haemoglobin receptor.
Ontology highlight
ABSTRACT: Meningococcal disease caused by serogroup B Neisseria meningitidis remains an important health problem in many parts of the world, and there are currently no comprehensive vaccines. Poor immunogenicity, combined with immunological identity to human sialic acids, have hindered the development of a serogroup B conjugate vaccine, resulting in the development of alternative vaccine candidates, including many outer-membrane protein (OMP)-based formulations. However, the design of protein-based meningococcal vaccines is complicated by the high level of genetic and antigenic diversity of the meningococcus. Knowledge of the extent and structuring of this diversity can have implications for the use of particular proteins as potential vaccine candidates. With this in mind, the diversity of the menin
SUBMITTER: Evans NJ
PROVIDER: S-EPMC3068627 | biostudies-literature | 2010 May
REPOSITORIES: biostudies-literature
ACCESS DATA